Stock Rating Downgrade
In the last week the Value Trend Rating for AbbVie Inc (NYSE: ABBV) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
On 4/12/24, AbbVie Inc (NYSE: ABBV) stock declined by -3.1%, closing at $162.28. Trading volume in this decline was normal. The stock has declined -3.3% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, ABBV is expected to continue to be a major Value Builder.
AbbVie has a current Value Trend Rating of C (High Neutral). This rating combines inconsistent signals from two proprietary PTR measures of a stock's attractiveness. AbbVie has a neutral Appreciation Score of 52 but a good Power Rating of 73, triggering the High Neutral Value Trend Rating.